Abstract PR-04: Phase 2 Trial Testing the PARP Inhibitor Niraparib in Patients with Advanced Pancreatic Cancer with Pathogenic Variants in BRCA 1, BRCA2, PALB2, ATM and CHEK2 Brandon M. Huffman , Jett Crowdis , Matthew B. Yurgelun , Nora Horick , Yvonne Li , Huy Nguyen , Kalindi Parmar , Bose S. Kochupurakkal , Andrea Enzinger , Marios Giannakis , Nadine McCleary , Kimmie Ng , Anuj K. Patel , Kimberly J. Perez , Douglas A. Rubinson , Benjamin L. Schlechter , Harshabad Singh , Helen Lam , Kaitlyn Ramsey , Elizabeth Andrews , Leigh Culnane , Andrea Bullock , Ahmed Rattani , Jeffrey Clark , Mary Linton Peters , Brian M. Wolpin , Alan D. D'Andrea , Geoffrey I. Shapiro , Andrew J. Aguirre , James M. Cleary Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
